KalVista Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
11.90
-0.29
(-2.38%)
Volume:
377,248
52 week range:
7.30 - 15.50
Market Cap:
591.616M
Company Description:
KalVista Pharmaceuticals, Inc. discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME) products.